pendulum health glp 1 GLP-1 Probiotic PRO Pendulum Glucose Control Pro Probiotic

("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that new clinical data from the company's VK2735 obesity program were highlighted in a poster presentation at ObesityWeek 2025, the annual meeting of The Obesity Society

Results All countries had at least one new antidiabetic medicine in continuous use and an increase in intensity of prescribing policy for all antidiabetic medicines was observed

These drugs improve glycemic control and promote weight loss, but they can cause gastrointestinal side effects such as gastroparesis ...

Learn about Farxiga side effects, from common ones like increased urination to more serious